Objective: The role of chymase (a mast cell-derived angiotensin II-forming serine proteinase) in aortic lipid deposition was investigated using an orally active, non-peptide chymase inhibitor, SUN-C8257. Methods: Male golden Syrian hamsters, 8 weeks old, were fed with a standard rodent meal supplemented with or without 0.5% cholesterol and 10% coconut oil for 12 weeks. The hamsters fed high cholesterol diet were further separated into two groups treated with or without SUN-C8257 for 12 weeks. The aortic lipid deposition was visualized by Oil red O staining and planimetrically measured. Immunohistochemical staining for angiotensin II (Ang II) of the aortic root region was performed. Aortic Ang II-forming activity was measured using Ang I as a substrate. Plasma total-, low-density lipoprotein (LDL)-, high-density lipoprotein (HDL)-cholesterol and triglyceride were quantified by enzymatic methods. Plasma Ang I and Ang II were measured by radioimmunoassay. Results: After 12 weeks of high cholesterol diet, aortic chymase activity in the untreated group increased significantly and showed a positive correlation with plasma total-and LDL-cholesterol. This group of hamsters developed marked lipid deposits in the aortic intima. However, treatment with SUN-C8257 significantly suppressed aortic lipid deposition without changing body weight, blood pressure, plasma LDL-cholesterol and Ang II levels. The level of the adventitial Ang II-immunoreactivity was markedly inhibited in the group treated with SUN-C8257. Conclusion: Our results suggest that arterial chymase may participate in the acceleration of lipid deposition in arterial walls exposed to high plasma cholesterol and that inhibition of arterial chymase may retard the progression of atherosclerosis. 
. Introduction
demonstrated the existence of alternative Ang II-forming pathways involving several serine proteinases, such as Activation of the tissue renin-angiotensin system (RAS) kallikrein, cathepsin G and chymase, which are probably appears to be involved in progression of atherosclerosis in responsible for ACE-independent Ang II-forming pathexperimental animals [1] as well as in humans [2] . This ways [4] [5] [6] . In humans, the tissue content of chymase is concept is substantiated by the finding that the activity of quite high in several organs [7] . Our recent clinical study aortic angiotensin converting enzyme (ACE) and density has shown that human atherosclerotic aortas contain of angiotensin II (Ang II) type 1 receptor (AT -R) are both significantly higher levels of chymase-dependent Ang II-1 significantly higher in rabbits fed a high cholesterol diet forming activity (dAIIFA) compared to non-atherosclerotic than in controls [3] . Furthermore, various studies have aortas [8] . In addition, the chymase dAIIFA of internal thoracic arteries obtained from coronary bypass operations correlated positively with serum low-density lipoprotein and that it may play an important role in atherogenic previously described method [8, 9] . Briefly, aortic homogedevelopment. Therefore, the anti-atherogenic effect of nate suspensions were incubated with authentic substrate orally active chymase-specific inhibitor was challenged in Ang I and the formed Ang II was analyzed by reversedthe hamsters fed a high cholesterol diet.
phase high performance liquid chromatography (HPLC, Shimazu, Kyoto, Japan) using a C reversed-phase HPLC 18 column (2.2325 cm; Vydac, Hesperia, CA, USA) with a 15-min linear acetonitrile gradient (3-13%) in 25 mM 2 . Methods triethylamine-phosphate buffer, pH 3, at a flow rate of 2 ml / min. To determine the captopril or chymostatin-inhib-2 .1. Diet and drug control for hamsters itable Ang II formation, incubations were performed with or without 100 mmol / l captopril or 10 mmol / l chymosMale golden Syrian hamsters (KBT Oriental Co.), 8 tatin, respectively. Ang II-forming activities were exweeks old and weighing 100-130 g, were selected because pressed as nmol of Ang II formed / min / mg protein. All they possess human-like Ang II-forming chymase. The analyses for each sample were performed in duplicate and hamsters were housed in a rodent cage on wood-chip the reproducibility and quality of all of the data were bedding and allowed free access to food and water (4-6 confirmed before the statistical analysis. The inter-and housed per cage). The standard chow group (n56) reintra-assay coefficients of variation of this assay were 8.6% ceived standard rodent meal. The high-cholesterol and (n512) and 5.1% (n510), respectively. high-fat chow group received a standard rodent meal Plasma total-, LDL-, high density lipoprotein (HDL)-supplemented with 0.5% cholesterol and 10% coconut oil cholesterol and triglyceride were quantified by enzymatic (KBT Oriental Co). The hamsters fed on high-cholesterol methods [11] . Plasma and aortic Ang I and Ang II levels and high-fat diet were treated with (n56) or without were measured by the method previously described [12] . In SUN-C8257 (n56) added to the drinking water (100 mg brief, peptides in hamster plasma were extracted by ethanol 21 kg per day, continuously) for 12 weeks. The invesprecipitation and Sep-Pak purification. The residues contigation conforms with the Guide for the Care and Use of taining Ang II were separated by a C reversed-phase 18 Laboratory Animals published by the US National Insti-HPLC column and the peak corresponding to authentic tutes of Health (NIH Publication No. 85-23, revised 1996).
standard Ang II was collected to measure Ang II conAll animal experiments were approved by our institutional centration by radioimmunoassay. committee and were performed according to its guidelines.
The chymase inhibitor, The aorta from its junction with the heart to its mid Osaka, Japan and is highly specific for human chymase.
portion of the ascending aorta was removed, and rinsed in The IC values for human chymase, hamster chymase, ice-cold saline. Segments 3-5 mm in length, containing 50 human cathepsin G and bovine pancreas chymotrypsin are the aortic cusp region, were cryopreserved in Tissue-Tek 0.31, 0.68, 5.5 and .10 mmol / l, respectively [10] .
O.C.T. Compound (Sakura Finetek, Torrance, CA, USA) at 280 8C. Transverse frozen sections of 6 mm were cut and placed on glass slides. To determine lipid deposition, 2 .2. Blood pressure measurement sections were fixed in 10% formalin for 10 min, rinsed in distilled water, and stained with Oil red O solution (Muto Hamsters were anesthetized with an intraperitoneal Pure Chemicals, Tokyo, Japan) which was preheated to injection of 5% sodium thiobutabarbital (final dose: 100 60 8C, for 5 min. Sections were rinsed with 60% isomg / kg body weight, Sankyo, Tokyo, Japan). Steady state propanol for 2 min and distilled water and counterstained heart rate and systolic blood pressure were measured by with hematoxylin for 2 min with rinsing in quarter the standard hind-limb cuff method with an MK-1100 saturated LiCO . These were subsequently used to assess 3 (Muromachi Kikai, Tokyo, Japan). the area of lipid deposition. The positive area at the level of coronary ostia was planimetrically measured using NIH Image software v1.61. The area of each lesion was 2 .3. Biochemical assays expressed relative to the cross-sectional area of the total intima and media. At the end of the study, aortic tissue was quickly
Immunohistochemical staining for Ang II in frozen removed from each hamster and rapidly washed in ice-cold sections from the hamster aortic root region was performed saline, immediately frozen in liquid nitrogen and subby a previously described method [8] . Rabbit anti-human sequently analyzed for chymase, ACE and non-ACE nonAng II polyclonal antibody (CHEMICON International, chymase dAIIFA. This was performed according to a Temecula, CA, USA) was used at 500-fold dilution.
Sections were mounted without counterstaining to obtain a 3 . Results clearer Ang II immunoreactivity.
.1. Effects of high cholesterol diet and co-treatment with chymase inhibitor 2 .5. Measurement of chymase and ACE expressions
After taking the high cholesterol diet, plasma total, Aortic tissue was quickly removed from each hamster LDL-, and HDL-cholesterol levels significantly increased and rapidly washed in ice-cold saline and then immediately (Table 1) . Hamsters receiving a high cholesterol diet frozen in liquid nitrogen. Aortic chymase and ACE mRNA exhibited significantly higher aortic chymase dAIIFA than levels were determined by a method of semiquantitative the control group (Fig. 1a) . Aortic ACE dAIIFA increased, reverse transcriptase polymerase chain reaction (RT-PCR).
but this was not statistically significant (Table 1 ). There The PCR primer for hamster chymase, ACE and b-actin was a significant positive correlation between aortic were selected according to the hamster cDNA sequence chymase dAIIFA and plasma total cholesterol or LDL-(chymase: sense primer, 59-AAT CGC TCA CCC AAA cholesterol levels of the hamsters fed with or without a CTA CAG C-39, antisense, 59-GCA GAC CTG GAA GTC high cholesterol diet (Fig. 1a) . In addition, the hamsters fed ATA ACT G-39, ACE: sense primer, 59-GCT TGC CCA a high cholesterol diet developed lipid deposition in the ACA AGA CTG CCA-39, antisense, 59-CCA CAT GTC ascending aortas (Fig. 2d) . In a separate group, a specific TCC CAG CAG ATG-39, b-actin: sense primer, 59-TCC non-peptide chymase inhibitor (SUN-C8257) was adminis-TGA CCG AGC GTG GCT ACA GC-39, antisense, 59-tered to hamsters receiving the high cholesterol diet. Such CTC CTG GAA GGT GGA CAG TGA GG-39). The PCR treatment significantly inhibited lipid deposition in the conditions for hamster chymase, ACE, and b-actin conascending aortas (Figs. 1b and 2a and c). The following sisted of denaturation at 94 8C for 1 min, annealing at 56, parameters were not significantly different between the 68, or 64 8C for 1 min and extension at 72 8C for 1 min for SUN-C8257-treated and untreated groups (Table 1) : body a total of 40, 35, or 30 cycles, respectively. Amplification weight, right hind-limb cuff blood pressure at week 11, of chymase, ACE and b-actin mRNA by the specific plasma total-cholesterol, LDL-cholesterol, plasma triprimers, gave an expected 277, 388 and 488 bp product, glyceride, plasma and aortic Ang II levels. SUN-C8257 respectively. The inter-and intra-assay coefficients of significantly decreased plasma HDL-cholesterol levels variation of this assay were 9.2% (n58) and 7.2% (n57), (Table 1) . The aortic chymase dAIIFA significantly derespectively.
creased by treatment with chymase inhibitor for 12 weeks (Fig. 1c) , but the aortic ACE dAIIFA did not (Table 1 ).
.6. Statistical analysis
Both cardiac chymase and ACE expressions significantly increased in the cholesterol diet-fed group and treatment Values are expressed as the mean6standard deviation. A with the chymase inhibitor significantly suppressed the standard linear regression analysis was used to compare elevated aortic chymase and ACE expressions (Fig. 1d) . tissue Ang II-forming activity to plasma cholesterol levels. Multiple comparisons among the groups were carried out 3 .2. Aortic immunohistochemistry for Ang II by both one-way ANOVA with Fisher's exact test for post hoc analysis and non-parametric analysis with MannThe intensity of aortic Ang II immunoreactivity slightly Whitney U-test. A probability value of less than 0.05 was increased in hamsters fed high cholesterol diet ( Fig. 2f and considered significant. g). In addition, the increased aortic Ang II immuno- reactivity was markedly suppressed by treatment with since recent studies have shown direct evidence that Ang II SUN-C8257; this suppression was limited to the adventitia is involved in atherogenesis in vivo [13, 14] . For example, (Fig. 2h) .
an AT receptor antagonist decreases lipid peroxidation 1 and mean atherosclerotic lesion area by 80% in apo-E deficient mice [13] . Similarly, in the monkey, AT receptor 1 4 . Discussion antagonists reverse the development of atherosclerotic lesion by |50% together with the decrease in monocyte Our results indicate that aortic chymase is involved in chemoattractant protein-1 and in vitro oxidation of LDL lipid deposition because a high cholesterol diet induced [14] . These data clearly demonstrate the proatherogenic atherogenic lesion formation and increased aortic chymase effects of Ang II and support our conclusion that chymaseexpression and activity. These changes were significantly mediated arterial Ang II formation is also an accelerator of inhibited by treatment with the orally active chymase atherogenic lesion formation. inhibitor, SUN-C8257. In addition, the chymase inhibitor
The increased adventitial Ang II immunoreactivity of did not affect blood pressure, body weight, and plasma the hamster aorta was suppressed by treatment with SUN-LDL-cholesterol levels. These facts indicated that the C8257. This may reduce Ang II-dependent atherogenic inhibitory action of SUN-C8257 on aortic lipid deposition stimulatory signals, which include monocyte migration was due to the inhibition of the proteolytic activity of [15] , oxidized LDL uptake to macrophage [16] and chymase and was not due to the changes in LDL-cholesproduction of superoxide [17] . Although the location of terol metabolism or appetite.
chymase-dependent Ang II formation in the adventitia is The reduction in the aortic Ang II seems to provide a distant from the intimal lesion area, Wilcox et al. have potent impact on the reversal of atherosclerotic changes, shown that the arterial adventitia is involved in the development of neointimal lesions in atherosclerosis [18] . number of various inflammatory cells including mast cells Experimental hypercholesterolemia in pigs and non-human were localized in the adventitia of the human atherosprimates stimulates the accumulation of inflammatory cells clerotic aorta. In addition, an experimental study provided in arterial adventitia. Furthermore, the extent of the direct evidence that chronic adventitial stimulation with inflammatory process in the adventitia of atherosclerotic interleukin (IL)-1b, a cytokine known to be involved in the plaques correlates with the severity of intimal disease [18] . development of atherosclerosis, induced intimal lesions These experimental observations were also confirmed with and vasospastic responses in the coronary artery of pigs the clinical data [8, 19, 20] . Those studies showed that a [21] . Since human chymase is known to convert the IL-1b precursor to active IL-1b [22] , we hypothesize that adgests that our present results obtained in hamsters may not ventitial chymase is involved in the development of intimal be directly applicable to humans. atherosclerosis [23] .
The present study describes for the first time the antiAlthough the plasma and aortic levels of Ang II did not atherogenic effect of a newly developed orally active change significantly after SUN-C8257 treatment, a reducchymase inhibitor and suggests that inhibition of arterial tion of Ang II limited in the adventitia may not have been chymase may retard the progression of atherosclerosis in detected in the assay for total measurement of aortic Ang the hamster. II. Similarly, total measurement of Ang II levels by radioimmunoassay could not detect a small change in plasma or aortic Ang II levels. In turn, our data suggested A cknowledgements that chymase inhibition did not cause an elevation in plasma and / or aortic Ang II concentrations.
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termined in the present study, therefore, the effects of these [26], indicating that the increased HDL-cholesterol may
